Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations

por Field, Stephen K.
Publicado 2011

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

por Giembycz, Mark A, Field, Stephen K
Publicado 2010

The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis

por Edwards, Brett D., Field, Stephen K.
Publicado 2022

Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta

por Lim, Rachel, Jarand, Julie, Field, Stephen K., Fisher, Dina
Publicado 2016

Congenital tuberculosis in an extremely preterm infant conceived after in vitro fertilization: case report

por Samedi, Veronica, Field, Stephen K., Al Awad, Essa, Ratcliffe, Gregory, Yusuf, Kamran
Publicado 2017

The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health

por Thornton, Christina S., Mellett, Madeline, Jarand, Julie, Barss, Leila, Field, Stephen K., Fisher, Dina A.
Publicado 2021

Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel

por Kum, Elena, Guyatt, Gordon H., Munoz, Caroline, Beaudin, Suzanne, Li, Shelly-Anne, Abdulqawi, Rayid, Badri, Huda, Boulet, Louis-Philippe, Chen, Ruchong, Dicpinigaitis, Peter, Dupont, Lieven, Field, Stephen K., French, Cynthia L., Gibson, Peter G., Irwin, Richard S., Marsden, Paul, McGarvey, Lorcan, Smith, Jaclyn A., Song, Woo-Jung, O'Byrne, Paul M., Satia, Imran
Publicado 2022